The European Molecular Biology Organization (EMBO) has announced the introduction of EMBO Molecular Medicine, a new journal dedicated to a research discipline focused on the interface between molecular biology and clinical research. The new journal, slated for launch in 2009, will publish original research offering molecular insights into cellular and systemic processes underlying defined human diseases as well as potential clinical applications for diagnosis, prevention and therapy.
According to EMBO, a renowned group of senior editors and advisory board will assure published articles of the highest scientific quality following rapid, transparent and rigorous peer review. The journal is expected to offer an opportunity to broadly distribute new findings in biomedical research and to strengthen links between clinicians and molecular biologists. It is hoped that published papers will lead to advances that will improve the detection, diagnosis and clinical management of diseases. Articles will appear online and in print. In addition to research articles, the journal will publish review articles and editorials with innovative formats targeting a broad and unspecialised audience. A new format of review article, called Bridging the Gap, will aim to help molecular biologists and clinical researchers to understand each other's perspectives and to define common goals.
Submissions are invited from research groups at universities, independent research laboratories and pharmaceutical and biotechnology companies worldwide.EMBO Molecular Medicine, published for EMBO by Wiley-Blackwell, offers free access to all content for the first two years of publication. EMBO's other peer-reviewed journals include The EMBO Journal, EMBO Reports and Molecular Systems Biology.
